1. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction;Swan;Pharmacotherapy,2000
2. Anticoagulant activity an pharmacokinetic properties of a subcutaneously administered mixed micellar formulation of argatroban in experimental animals;Berry;Thromb. Haemost.,2000
3. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia;Lewis;Cather Cardiovasc. Interv.,2002
4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia;Lewis;Arch. Intern. Med.,2003
5. Argatroban for treatment of heparin-induced thrombocytopenia;Medical Letter;Medical Letter on Drugs and Therapeutics,2001